We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Genedrive Plc | LSE:GDR | London | Ordinary Share | GB00B1VKB244 | ORD 1.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 2.40 | 2.30 | 2.50 | 2.40 | 2.40 | 2.40 | 14,156 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Coml Physical, Biologcl Resh | 55k | -5.15M | -0.0095 | -2.53 | 13.04M |
Date | Subject | Author | Discuss |
---|---|---|---|
17/11/2024 17:31 | With the products dispersal in various parts of the NHS and even being named as Genedrive....which is very pleasing.... there has to be some sort of acknowledgement and announcement soon, I would have thought. Amusing to see the sister thread talking about everything but Genedrive! IMO | hazl | |
17/11/2024 17:23 | More than cost cutting in prescription, as the government is discussing the Assisted Dying Bill. They want to kill off all kinds of vulnerable people legally as a subtle way saving cost to the health service. | kingston78 | |
17/11/2024 15:29 | To cut costs, the NHS is also scr@pping certain prescriptions over the GP counter. Items like paracetamol, eye drops, sun creme, nasal sprays etc. Patients are encouraged to go buy at pharmacies instead. I'm not making this up, it's an known issue and it has been reported in the media today. Go look it up. Stating the obvious here, but the NHS is tight on funds. The people that are saying the NHS will fund hundreds of thousands, or even a few millions for GDR's kits that are on prototype/trial stages are del_uded, in my opinion. | batiatus | |
17/11/2024 12:15 | Despite the share price down a tad, on the whole, it has been a nice even trajectory lately. A good sign, in my book. There are people holding on for news and filling any gaps, it seems. We will see in the fullness of time. | hazl | |
17/11/2024 11:33 | Farmers are protesting about the Labour government's inheritance plan on farms. I think the Chancellor will tax all motorists heavily next year. I would suggest that she taxes all members of the Cabinet at 90% income tax rate to lead by example to show their support for the country. Anyway, the NHS has no spare money. It is fire fighting on many fronts. They will not buy any new equipment. | kingston78 | |
15/11/2024 11:31 | i would expect the update next week on this one. Good luck. | porky9 | |
15/11/2024 10:58 | bones tried to make a quick profit over at MATD yesterday. I tried to warn him like I do here. Looks like another loss for bones... | batiatus | |
15/11/2024 10:21 | POLX Polarean Imaging about to break out above 2p soon. Mcap is peanuts and cash position is much longer to Q2 2026 and revenue are higher and growing even more quickly than this.. I see it as a steal for the FDA approved Xenon MRI. No company debt, masssive growth potential in the worlds biggest health market the United States where it's already in 21 clinical settings, best in class next generation MRI. Revenues rising up 3000% to $3mil for 2024 and doubling again next to $6mil. 1.55p and gap at over 3p. ATH 100p. Cash runway to minimum of Q2 2026, looks set to be extended given revenues ahead of expectations. Putting this UK recovery play potential on radars. 1. September 18th 2024: Interventional radiology vendor Merit Medical to acquire device portfolio for $210M. APPROX 13P SHARE PRICE EQUIVALENT FOR POLX 2. September 25th 2024: Private equity firm acquiring diagnostic imaging provider for $658M APPROX 48P SHARE PRICE EQUIVALENT FOR POLX 3. October 14th 2024: Hologic to Acquire Gynesonics The women’s health company will be purchased for approximately $350 million. APPROX 22P SHARE PRICE EQUIVALENT FOR POLX 4. Bracco current major TR1 Holder of Polarean splashed out $450MILLION for a diagnostic buyout POLX easy buyout target more massive premiums as per the above imv. DYOR, not advice. | m_night10 | |
15/11/2024 09:40 | The irony... The naive punters are all here look to make money... But little did they know they are giving away their hard earns... The company is the one needing fundraise to keep them going... Totally opposite to what they are marketing... Shareholder value lmao 🤣 | batiatus | |
15/11/2024 09:28 | Wonder which of those short posters here will crack first LoL. Last one to close their short takes a major bath when the update lands. Love it. | porky9 | |
15/11/2024 08:33 | Lack of news regarding contracts especially for MT-RNR1 kit is very disappointing. | saad112 | |
15/11/2024 07:41 | They have saved individuals from hearing loss, already. Enough said as far as I am concerned. When there is a demise of values... as seen on the sister thread it's a sad day indeed. IMO | hazl | |
15/11/2024 07:14 | David Budd the ex CEO Took 550k PA when GDR was facing bankruptcy He missed the COVID testing calamity After pumping millions in to a test / never used and shelved. 100k sales in a decade Nothing else to say here Worth a punt at 1.5 maybe Even then .. wouldn’t set the house on fire | washingmachine | |
15/11/2024 07:06 | Lost count on the number of days without sales or profit. | batiatus | |
14/11/2024 16:50 | Bones you didn't buy MATD did you? If so, your attempt on making a quick profit didn't work out Same mistake just like how you got locked into GDR? | batiatus | |
14/11/2024 16:15 | Harder work talking it up because you you don't have concrete evidence to back up the points you're making, neither has your success scenarios had happened yet, because they're all speculation and hype. Meanwhile, I refer to the facts. I'm sure you heard many times but the company isn't making a penny profit. Cash burn of £400-600k monthly. And no, they do not have money to last for 18 months, up to June 2025 at most. With this sort of cash burn model, they are deemed to fail. And don't say shareholders have not given them enough time. 9 months to make £100K worth of sales. 10 years plus without a commercially viable product. The company exists today through countless fund raises. Based on the past and present, all evidence isn't really convincing is it | batiatus | |
14/11/2024 14:57 | Harder work talking it up bones isn't it? You've been a replica of the one you berate. I haven't forgotten. However GDR has the best it's ever been! Come on prove your worth! genedrive plc @genedriveplc TODAY Genedrive are exhibiting at POCT-for-Scot! Stop by the stand to learn how... 👂Genedrive MT-RNR1 ID Kit can reduce the risk of antibiotic induced hearing loss in NICU patients. 👩b | hazl | |
14/11/2024 14:53 | Ah news! TODAY Genedrive are exhibiting at POCT-for-Scot! Stop by the stand to learn how... 👂Genedrive MT-RNR1 ID Kit can reduce the risk of antibiotic induced hearing loss in NICU patients. 👩b | hazl | |
14/11/2024 13:58 | Looking good people! | hazl | |
14/11/2024 13:38 | Novacyt moving operations to Manchester, I wonder why Manchester. It wouldn't have anything to do with Genedrive would it. | uxbridgearms |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions